- Sellas Life Sciences Group Inc Corporate Update Call TranscriptJan 03, 2024
- Sellas Life Sciences Group Inc Expert Panel Discussion TranscriptMay 30, 2023
- Sellas Life Sciences Group Inc to Host Key Opinion Leader Webinar TranscriptJan 31, 2023
- Sellas Life Sciences Group Inc Galinpepimut-S Update Call TranscriptNov 14, 2022
- Sellas Life Sciences Group Inc Galinpepimut-S Update Call TranscriptSep 15, 2022
- Sellas Life Sciences Group Inc Provides Business Update and First Quarter 2022 Highlights TranscriptApr 06, 2022
- Sellas Life Sciences Group Inc Virtual Investor Symposium Corporate Call TranscriptAug 17, 2021
- Sellas Life Sciences Group Inc Shareholder Update Call TranscriptJun 03, 2021
- Sellas Life Sciences Group Inc Annual Shareholders Meeting TranscriptJun 09, 2020
- Sellas Life Sciences Group Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Sellas Life Sciences Group Inc Corporate Analyst Meeting TranscriptNov 15, 2019
Sellas Life Sciences Group Inc Corporate Analyst Meeting Transcript
Well, good morning, everyone. I'm Angelos Stergiou, President and CEO of SELLAS. And a very warm welcome to our first R&D event. It's really an honor to be here today, and I'm very happy to see so many familiar faces, actually. And -- in the audience, and for those of us joining us via webcast, thanks for joining in. Firstly, I would like to thank our shareholders for their continued support. The Board and management are committed to the goal to create value for our shareholders and to develop life-saving drugs. We're very pleased to host because we had to share some exciting information and data around SELLAS' lead assets and program around galinpepimut-S or GPS in short. And so I'm just going to cut right to it. But first, we're going to be making forward-looking statements today, so please refer to the filing on our website to remind yourself of the risk factors.
Today, we hope to convey a theme really of growth and transformation since SELLAS started trading on NASDAQ last year, and we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)